GI Effects Comprehensive Profile 1 Day

GI Effects® is a comprehensive assessment of complete gut health, assessing the root cause of most GI complaints. The combination of PCR, culture, and microscopic testing methods ensures any and all relevant organisms are identified Data driven analysis is based on Genova Diagnostics' database of hundreds of thousands of complete stool profiles. 

The GI Effects Stool Profiles are a suite of advanced stool tests that provide immediate, actionable clinical information for the management of gastrointestinal health. Utilizing cutting-edge technologies and biomarkers, these profiles offer valuable insight into digestive function, intestinal inflammation, and the intestinal microbiome. 

The overview pages make results interpretation quicker and easier, to prioritize treatment and assess microbiome status. 

The GI Effects Stool Profiles can reveal important information about the root cause of many common gastrointestinal symptoms and non-GI conditions including: 

The health of the entire body is dependent on a healthy gut and gut microbiome. Gut microbes are codependent with one another and with their human host, and the health of one affects the other. A sizeable volume of research associates a dysbiotic, or imbalanced gut microbiome with multiple disease states both within and outside of the GI tract.

The diverse metabolic activities of the microbiome ultimately impact the human host, and the activities of the human host ultimately affect the health of their microbiome. The biomarkers on the GI Effects Comprehensive Profile (2200) reflect the 3 key functions of gut health arranged in the “DIG” format: Digestion/Absorption, Inflammation/Immunology, and the Gut Microbiome:
Digestion/Absorption:

Pancreatic Elastase-1 is a marker of exocrine pancreatic function. Products of Protein Breakdown are markers of undigested protein reaching the colon.

Fecal Fat is a marker of fat breakdown and absorption. Inflammation/Immunology: Calprotectin is a marker of neutrophil-driven inflammation. Produced in abundance at sites of inflammation, this biomarker has been proven clinically useful in differentiating between Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS).

Eosinophil Protein X is a marker of eosinophil-driven inflammation and allergic response. Fecal Secretory IgA is a marker of gut secretory immunity and barrier function.

Fecal Occult Blood Test detects hidden blood; fecal immunochemical testing (FIT) has been recommended by the American College of Gastroenterology as the preferred noninvasive test for colorectal cancer screening/detection. 

Estimated days for results: 10 business days